Tiberiu Stan
@tibisan.bsky.social
This work is part of a collaborative effort with #Synaffix, and I look forward to sharing our findings. If you’re attending #OTS, I invite you to visit our poster to learn more about our Validation Lab’s in vitro and in vivo platforms, as well as our new humanized DMD mouse models.
October 21, 2025 at 2:33 AM
Excited to attend the Oligonucleotide Therapeutics Society (OTS) Annual Meeting in Budapest!
👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”
👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”
October 21, 2025 at 2:30 AM
Excited to attend the Oligonucleotide Therapeutics Society (OTS) Annual Meeting in Budapest!
👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”
👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”
🔬 Research Technician Human Genetics
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...
Research Technician Human Genetics | LUMC
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? In our Validation Lab, you’ll work alongside a dedicated and skilled team ...
www.lumc.nl
April 14, 2025 at 10:24 AM
🔬 Research Technician Human Genetics
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...
A second paper from my former post doc lab in Lund has been accepted recently to EJN and I am sharing (again) the first authorship😊
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
Levodopa provides effective symptomatic treatment for Parkinson’s disease. However, non-motor symptoms are often insufficiently relieved, and its long-term use is complicated by motor fluctuations and...
www.authorea.com
February 21, 2025 at 10:16 AM
A second paper from my former post doc lab in Lund has been accepted recently to EJN and I am sharing (again) the first authorship😊
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...